A CNBC reporter since 1990, Bob Pisani has reported on Wall Street and the stock market from the floor of the New York Stock Exchange for more than a decade. Pisani covered the real estate market for CNBC from 1990-1995, then moved on to cover corporate management issues before moving to the New York Stock Exchange in 1997.
He was nominated twice for a "CableACE Award"—in 1993 and 1995.
In 2013, he won Third Place in the National Headliner Awards in the Business and Consumer Reporting category for his documentary on the diamond business, "The Diamond Rush."
In 2014, Bob was honored with a Recognition Award from the Market Technicians Association for "steadfast efforts to integrate technical analysis into financial decision making, journalism and reporting."
Prior to joining CNBC, Pisani co-authored "Investing in Land: How to Be a Successful Developer." He and his father taught a course in real estate development at the Wharton School of Business at the University of Pennsylvania from 1987-1992. Pisani learned the real estate business from his father, Ralph Pisani, a retired real estate developer.
Follow Bob Pisani on Twitter
What's up with the Fed this week? They will almost certainly cut rates a quarter point and signal that the period of cutting rates is coming to a close. The bond market believes this; look what happened to yields on the 2-year note last week. .
Has S&P improved ability to weather cyclical risks? David Bianco at UBS and others think so. I have remarked many times that with many non-financial S&P companies receiving 50 percent and more from overseas, their earnings have remained relatively strong. Non-financial earnings growth in the first quarter is about 10 percent, a typical performance is up 6-8 percent.
European bourses are advancing again today; the FTSE, like the Dow, finally broke through to its highest levels since January; same with France's CAC 40. The Euro is down slightly, even though German consumer confidence rose to the highest since Oct '07.
Stocks mostly weaker today. Two factors: concern that the Fed's period of rate cuts is coming to an end (on this, commodities and commodity stocks are down, dollar is rallying); and the dismal new home sales number, at a 13 year low. No sign of a bottom here: unsold inventories remain at multi-decade highs...
Better-than-expected economic numbers this morning have moved futures up about 8 points; the dollar rallied and bonds dropped. Talk about food inflation -- Potash has been the beneficiary here. Same story from Bunge, one of the largest agribusiness companies.
GlaxoSmithKline is paying big in an effort to find cures for diseases of aging. They are buying Sirtris Pharmaceuticals for $720M in cash, or $22.50/share. This price represents an 84% premium over SIRT's closing price yesterday. Two things are going on here...
Stocks fall across the globe amid growth fears. Commodities and emerging markets lag.
Now that Alibaba's record-breaking offering is out of the way, global markets are gearing up for a raft of new recruits.
Investors go bonkers for Alibaba. The stock finally opened just before noon.
No, Alibaba doesn't actually cure cancer; however, some traders say it's lifting stocks ahead of its IPO tomorrow.
Bank of America could see its shares climb 50 percent over the next three years, Barron's financial newspaper said on Sunday.
Protesters will risk arrest during an unsanctioned blockade in New York City's financial district to call attention to climate change.
Investors may find it time to adjust portfolios as they focus on Fed speakers, economic reports, and the rising U.S. dollar in the week ahead.